Joel Greenblatt’s Balchem Corp BCPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,220
Closed -$203K 1760
2025
Q1
$203K Sell
1,220
-255
-17% -$41.8K ﹤0.01% 1466
2024
Q4
$240K Buy
+1,475
New +$256K ﹤0.01% 1320
2024
Q3
Sell
-2,961
Closed -$456K 1540
2024
Q2
$456K Buy
2,961
+896
+43% +$135K 0.01% 1104
2024
Q1
$320K Buy
+2,065
New +$306K ﹤0.01% 1168
2022
Q3
Sell
-2,365
Closed -$307K 1284
2022
Q2
$307K Sell
2,365
-2,691
-53% -$337K 0.01% 935
2022
Q1
$691K Buy
+5,056
New +$724K 0.02% 689
2021
Q3
Sell
-2,386
Closed -$313K 1141
2021
Q2
$313K Buy
+2,386
New +$307K 0.01% 833
2014
Q3
Sell
-20,537
Closed -$1.1M 1081
2014
Q2
$1.1M Buy
20,537
+10,368
+102% +$595K 0.01% 629
2014
Q1
$530K Buy
+10,169
New +$546K 0.01% 780

Other funds holding BCPC

Joel Greenblatt's BCPC Position: Q2 2025 in Review

Joel Greenblatt sold out of Balchem Corp (BCPC) in Q2 2025, closing a stake of 1,220 shares — an estimated $203K sold.

Joel Greenblatt first reported a position in BCPC in Q1 2014 and held it in 9 quarters. The position peaked at $1.1M in Q2 2014. 396 funds tracked by Wall St. Rank hold BCPC as of Q2 2025.

  • Joel Greenblatt reported no remaining Balchem Corp position as of Q2 2025 after selling out during the quarter.
  • Joel Greenblatt sold 1,220 Balchem Corp shares in Q2 2025, an estimated $203K.
  • Joel Greenblatt first reported a position in Balchem Corp in Q1 2014 and held it in 9 quarters.
  • Joel Greenblatt's Balchem Corp position peaked at $1.1M in Q2 2014.
  • 396 funds tracked by Wall St. Rank held Balchem Corp as of Q2 2025.

Based on Gotham Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.